Pediatric Plaque Psoriasis

Clearer skin is possible for patients 6+

SKYRIZI is approved for children and teens (ages 6+) with moderate to severe plaque psoriasis

If you are dealing with plaque psoriasis for your child, or yourself, you are not alone. Approximately 1/3 of all psoriasis cases start before age 18. With SKYRIZI, children and teens have the opportunity to reach their treatment goals.

SKYRIZI has an established safety profile in children, teens, and adults

In a clinical trial of children and teens with plaque psoriasis, the safety profile of SKYRIZI was consistent with what was observed in adult patients with plaque psoriasis.

No daily dosing
Only 4 doses a year, after 2 starter doses

Each dose of SKYRIZI consists of either a 55 mg/0.37 mL or a 150 mg/mL injection. The actual dose your child receives is dependent on their weight.

55 mg/0.37 mL pre-filled syringe
for pediatric patients 6+ who weigh less than 88 lbs (40 kg)

OR

150 mg/mL pre-filled pen (or syringe)
for pediatric patients 6+ who weigh 88 lbs (40 kg) or more or for adults

Administering SKYRIZI

Injections can be administered at home or in a doctor's office.

  • For pediatric patients 6 to less than 10 years of age, SKYRIZI should be administered by an adult
  • For pediatric patients 10 years of age and older, it is recommended that SKYRIZI be administered by or under the supervision of an adult
  • Caregivers and children 10 and older should be trained on how to inject by a healthcare professional

Learn more about how to inject SKYRIZI

2 starter doses in week 1 and week 4. After, doses are in weeks 16, 28, 40, and 52, yearly.

Ways to make the administration environment more comfortable for children

Caregivers may also want to create a comfortable environment for children or teens (ages 6 and older). Some ideas include:

Breathing
techniques

Emotional support stuffed animals or blankets

Using a reward
system

Find out how you can get help paying for SKYRIZI

Learn about ways to save